Navigation Links
Sea snail saliva may become new treatment for most severe pain
Date:7/28/2010

Scientists have developed a new version of a medication, first isolated from the saliva of sea snails, that could be taken in pill form to relieve the most severe forms of pain as effectively as morphine but without risking addiction. An article on the topic appears in the current issue of Chemical & Engineering News (C&EN), ACS' weekly newsmagazine.

C&EN Senior Editor Bethany Halford notes that a sea snails' saliva contains chemicals that help the slow-moving creatures catch prey. They include chemicals that the snails inject into passing prey with hypodermic-needle-like teeth that shoot from their mouths like harpoons. Scientists already have transformed one of these chemicals into a pain-reliever for humans, but it has to be injected directly into the spinal cord, limiting its use.

Now scientists in Australia have developed a form of the painkiller that can be given by mouth. It relieves severe pain, such as that in people with peripheral neuropathy, at a much lower dose than existing medications and without the risk of causing addiction. The article quotes one expert as speculating that such a drug could revolutionize the treatment of the most severe forms of pain.


'/>"/>

Contact: Michael Bernstein
m_bernstein@acs.org
202-872-6042
American Chemical Society
Source:Eurekalert

Page: 1

Related biology news :

1. Can you make a snail forget?
2. Presence of snails points to forest recovery
3. The fantastic armor of a wonder snail
4. National assessment done on potential invasive snail and slug pests in US
5. Penn biologists demonstrate that size matters... in snail shells
6. Snails and humans use same genes to tell right from left
7. UH Manoa researchers release results of statewide survey of snail, slug invasions in Hawaii
8. Ripple effect: Water snails offer new propulsion possibilities
9. First preliminary profile of proteins in bed bugs saliva
10. Answer to saliva mystery has practical impact
11. Solution to beading-saliva mystery has practical purposes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/3/2016)... , February 4, 2016 --> ... SEK 1,351.5 M (105.0), up 1,187% compared with fourth quarter of 2014. ... to SEK 517.6 M (loss: 30.0). Earnings per share increased ... was SEK 537.4 M (neg: 74.7). , ... Revenues amounted to SEK 2,900.5 M (233.6), up 1,142% compared with 2014. ...
(Date:2/2/2016)... , Feb. 2, 2016 This BCC ... bioinformatic market by reviewing the recent advances in ... that drive the field forward. Includes forecast through ... Identify the challenges and opportunities that exist in ... software solution developers, as well as IT and ...
(Date:2/1/2016)... -- Rising sales of consumer electronics coupled ... gesture control market size through ... electronics coupled with new technological advancements to drive global ... through 2020   --> Rising ... to drive global touchfree intuitive gesture control market ...
Breaking Biology News(10 mins):
(Date:2/9/2016)... of Prussia, PA (PRWEB) , ... February 09, 2016 , ... ... Business Development, Europe. Based in Paris, he will focus on acquiring new accounts ... are being met. , “Fred brings to our European clients more ...
(Date:2/9/2016)... Feb. 9, 2016  DNAtrix, a clinical ... cancer, announced that its lead product, DNX-2401, ... as an orphan medicinal product for the ... of glioma, strikes approximately 25,000 people a ... http://photos.prnewswire.com/prnh/20160208/330986LOGO --> ...
(Date:2/9/2016)... 2016 BERG, a biopharmaceutical company uncovering ... has announced the appointment of Jason Haddock ... Officer. Haddock brings to BERG over 20 years ... in senior financial functions at pharmaceutical companies, as ... management. Niven R. Narain , ...
(Date:2/8/2016)... , Feb. 8, 2016  CytRx Corporation (NASDAQ: ... company specializing in oncology, today announced that it ... agreement with Hercules Technology Growth Capital, Inc. and ... million in financing. --> ... $25 million of financing under the loan and ...
Breaking Biology Technology: